Bradley Foster & Sargent Inc Novartis Ag Transaction History

Bradley Foster & Sargent Inc

  • $5.77 Billion
  • Q4 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Novartis Ag stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 28,758 shares of NVS stock, worth $3.03 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
28,758
Previous 28,883 0.43%
Holding current value
$3.03 Million
Previous $3.32 Million 15.77%
% of portfolio
0.05%
Previous 0.06%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025
SELL
$96.78 - $117.18 $12,097 - $14,647
-125 Reduced 0.43%
28,758 $2.8 Million
Q3 2024

Nov 04, 2024
SELL
$106.13 - $120.89 $52,534 - $59,840
-495 Reduced 1.68%
28,883 $3.32 Million
Q2 2024

Aug 09, 2024
SELL
$92.57 - $107.37 $38,786 - $44,988
-419 Reduced 1.41%
29,378 $3.13 Million
Q1 2024

May 15, 2024
SELL
$95.27 - $108.47 $244,843 - $278,767
-2,570 Reduced 7.94%
29,797 $2.88 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $467,070 - $513,995
-5,062 Reduced 13.52%
32,367 $3.27 Million
Q2 2023

Aug 08, 2023
SELL
$92.52 - $104.91 $23,130 - $26,227
-250 Reduced 0.66%
37,429 $3.78 Million
Q1 2023

May 08, 2023
SELL
$80.03 - $92.81 $34,572 - $40,093
-432 Reduced 1.13%
37,679 $3.47 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $93,833 - $114,909
-1,242 Reduced 3.16%
38,111 $3.46 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $71,998 - $84,205
-965 Reduced 2.39%
39,353 $2.99 Million
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $118,767 - $138,281
-1,475 Reduced 3.53%
40,318 $3.41 Million
Q1 2022

May 16, 2022
SELL
$80.11 - $90.62 $265,083 - $299,861
-3,309 Reduced 7.34%
41,793 $3.67 Million
Q4 2021

Mar 11, 2022
SELL
$79.7 - $88.13 $549,451 - $607,568
-6,894 Reduced 13.26%
45,102 $3.95 Million
Q3 2021

Nov 10, 2021
SELL
$81.78 - $95.14 $789,013 - $917,910
-9,648 Reduced 15.65%
51,996 $4.25 Million
Q2 2021

Aug 19, 2021
SELL
$85.24 - $94.15 $6.56 Million - $7.25 Million
-76,977 Reduced 55.53%
61,644 $5.62 Million
Q1 2021

Apr 26, 2021
SELL
$83.5 - $98.47 $2.82 Million - $3.33 Million
-33,817 Reduced 19.61%
138,621 $11.8 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $82,363 - $99,623
-1,055 Reduced 0.61%
172,438 $16.3 Million
Q3 2020

Oct 26, 2020
SELL
$82.14 - $91.0 $1.18 Million - $1.3 Million
-14,336 Reduced 7.63%
173,493 $15.1 Million
Q1 2020

May 07, 2020
BUY
$70.67 - $99.01 $124,379 - $174,257
1,760 Added 0.95%
187,829 $15.5 Million
Q4 2019

Jan 29, 2020
SELL
$84.35 - $95.37 $774,670 - $875,878
-9,184 Reduced 4.7%
186,069 $17.6 Million
Q3 2019

Oct 30, 2019
BUY
$85.54 - $94.26 $620,165 - $683,385
7,250 Added 3.86%
195,253 $17 Million
Q2 2019

Aug 08, 2019
BUY
$75.4 - $92.8 $1.2 Million - $1.48 Million
15,960 Added 9.28%
188,003 $17.2 Million
Q1 2019

May 02, 2019
BUY
$75.32 - $86.15 $237,182 - $271,286
3,149 Added 1.86%
172,043 $16.5 Million
Q4 2018

Jan 30, 2019
SELL
$73.66 - $82.02 $291,325 - $324,389
-3,955 Reduced 2.29%
168,894 $14.5 Million
Q3 2018

Oct 31, 2018
SELL
$66.94 - $77.43 $659,693 - $763,072
-9,855 Reduced 5.39%
172,849 $14.9 Million
Q2 2018

Jul 31, 2018
SELL
$64.91 - $73.36 $218,681 - $247,149
-3,369 Reduced 1.81%
182,704 $13.8 Million
Q1 2018

May 07, 2018
SELL
$70.39 - $84.15 $88,339 - $105,608
-1,255 Reduced 0.67%
186,073 $15 Million
Q4 2017

Feb 06, 2018
SELL
$72.33 - $77.64 $180,897 - $194,177
-2,501 Reduced 1.32%
187,328 $15.7 Million
Q3 2017

Nov 03, 2017
BUY
$74.14 - $77.27 $14.1 Million - $14.7 Million
189,829
189,829 $16.3 Million

Others Institutions Holding NVS

# of Institutions
1,462
Shares Held
132M
Call Options Held
1.33M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bradley Foster & Sargent Inc Portfolio

Follow Bradley Foster & Sargent Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email